Factors Affecting the Statural Growth Retardation in Children using Steroids in Idiopathic Nephrotic Syndrome
Aliou Abdoulaye Ndongo, Djibril Boiro, Idrissa Basse, Younoussa Kéita, Ndiogou Seck, Lamine Thiam, Tabitha D. Van Immerzeel, Assane Sylla
Asian Journal of Pediatric Research · pp. 70–76 · Published 20 Dec 2021
10.9734/ajpr/2021/v7i430225Abstract
Background and Aim: Idiopathic nephrotic syndrome or nephrosis causes massive protein leakage in the urine. Its treatment requires steroids (prednisone, methylprednisolone), often for a prolonged period, notably in case of steroid-dependence or steroid-resistance. In children, long-term use of steroids can lead to several side effects such as statural growth retardation/ stunting. This study evaluated the frequency of stunting in idiopathic nephrotic syndrome in children on steroids and identified the associated factors. Material and Methods: This was a retrospective, descriptive cohort study carried out in children aged 0 to 16 years treated at the paediatric nephrology unit of Aristide Le Dantec Hospital in Dakar, between 1 December 2017 and 31 May 2020. All records of nephrotic children treated in outpatient or inpatient setting were included. These children had to be on corticosteroid therapy for at least 30 months and have a height taken regularly during follow-up consultations. Results: Of 259 children followed for idiopathic nephrotic syndrome, 93 were included in the study. The median age was 96.5 months and the sex ratio was 1.9. The mean height of the children at the beginning of the follow-up was -0.26 DS, at the end it was -0.88 DS. At the beginning of the follow-up, 8 children had already stunting. At 12 months follow-up, 72 children (77.4%) had a decrease in z-score; and at 30 months, there were 7 more children (84.9%) who had a decrease in z-score. Methylprednisolone boluses were given to 17 children (18.3%). Calcium supplementation was done in 91 children (97.8%). Vitamin D supplementation was given to 91 children (97.8%). The mean number of relapses was 1.8. Factors associated with stunting were number of relapses ≤3 (p=0.03), duration of corticosteroid therapy >6 months (p<0.0001) and cumulative doses of prednisone >100 mg/kg (p=0.04). Conclusion: In prolonged nephrotic syndrome in children, corticosteroids can cause stunting.
Cited by 0
No indexed citations yet.
Related research
- Ear Diseases among Primary School Children in Ibadan Metropolis, Southwestern Nigeria — shares topic coverage
- Clinical Pattern of Acquired Thyroid Disorders in Childhood and Adolescents Attending Endocrine Unit, Tripoli Children Hospital — shares topic coverage
- Coagulation Profile of Children with Snake Envenomation in Yola, Nigeria — shares topic coverage
- Demographic, Clinical and Therapeutic Characteristics of Children Aged 0-15 years with Nephrotic Syndrome: A Retrospective Study of the Komfo Anokye Teaching Hospital, Kumasi, Ghana — shares topic coverage
- Accessibility of Children Living with HIV/AIDS to Hospitals in Ten Districts in Indonesia — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.